Double‐hit lymphoma (DHL) is an aggressive subtype of high‐grade B‐cell lymphoma with inferior prognosis using standard dose chemotherapy. Controversy remains whether more intensive chemotherapy regimens such as dose‐adjusted etoposide, prednisolone,… Click to show full abstract
Double‐hit lymphoma (DHL) is an aggressive subtype of high‐grade B‐cell lymphoma with inferior prognosis using standard dose chemotherapy. Controversy remains whether more intensive chemotherapy regimens such as dose‐adjusted etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin and rituximab (DA‐EPOCH‐R) provide better outcomes in this cohort.
               
Click one of the above tabs to view related content.